New combo therapy shows promise for Tough-to-Treat liver cancer
Disease control
Recruiting now
This study tests whether giving two immunotherapy drugs (durvalumab with or without tremelimumab) after a short course of radiation can shrink tumors in people with advanced liver cancer that has spread. About 21 adults whose cancer has worsened despite prior treatment will recei…
Phase: PHASE2 • Sponsor: Mary Feng, MD • Aim: Disease control
Last updated May 04, 2026 16:22 UTC